Issue Lab
Every day, more than 1,000,000 biopharmaceutical industry employees across the United States work to research, develop and manufacture lifesaving medicines and treatments. It is important to have public policies that encourage and support continued medical innovation, while also improving patient access to affordable medicines.
We aim to protect access, innovation and jobs.
Unfortunately, some policymakers have proposed policies that would chill investment in science, threaten access to medicines and put jobs at risk.
Employee Champions
Meet the recipients of the 2026 Employee Champions Awards. This award recognizes individuals who strive to advance science and support innovation so that patients around the world can get the medicines and treatments they need.
Emily Mason
National Vice President, Patient Access and Affordability Solutions
Astellas
Guthrie Zaring
Executive Sales Specialist, Biologics
AstraZeneca
Victoria Thomas
Sr. Area General Manager, Oncology, Tennessee Valley
Bayer
Savine DaCosta
Assoc Director, Clinical Trial Access & Representation Site Lead
Biogen
Phung Osborn
VP & Head of Global Market Access, Cell Therapy
Bristol Myers Squibb
Colleen Dodson
Healthcare Market Executive Director
Genentech
Oscar Merino
Principal Medical Science Liaison, West Regional MSL Lead Hematology
Genmab
Woodie Zachry
Senior Director, Medical Affairs
Gilead Sciences
Anton Lewis
Vice President, Head of Specialty Sales
GSK
Dr. Christopher Cutie
Vice President and Disease Area Leader, Bladder Cancer
Johnson & Johnson
Matthew Baca
Head of Operations, Novartis Indianapolis Radioligand Therapy
Novartis
Navin Katyal
President, US Commercial
Pfizer
Jeannette Novatski
Head of US HEOR Strategy
UCB